FdaApplication
ANDA 211182
Identifiers
- fda_app_no: ANDA211182
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT V |
| application_type | ANDA |
| approval_date | 2026-09-08 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IBRUTINIB | IBRUTINIB | 140MG | CAPSULE;ORAL |
1 product